Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Biomira reports phase II results for cancer vaccine

Sep. 15, 1997

New clinical study on Multikine initiated in Canada

Sep. 12, 1997

Regressin induces apoptosis and direct inhibition of tumor cell growth

Sep. 12, 1997

Safety study of Multikine in prostate cancer patients completed

Sep. 10, 1997

Ribi seeks approval for melanoma vaccine in Canada

Sep. 9, 1997

Vical's Allovectin-7 enters phase II for head and neck cancer

Sep. 8, 1997

TNT nears clinical trials

Sep. 2, 1997

FDA requests additional manufacturing data before approval of Rituxan

Sep. 1, 1997

Dovetail issued patent for Betathine

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...